23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s massive data breach and reverse its plummeting stock price. The genetic testing company also announced that it will shut down its therapeutics business.Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a result, while “substantially” lowering operating expenses.

23andMe正在解雇40%的员工，即200多名员工，该公司试图从去年的大规模数据泄露中恢复过来，扭转股价暴跌的局面。这家基因检测公司还宣布将关闭其治疗业务。尽管23andMe表示，重组计划将耗资约1200万美元，但预计将节省3500多万美元，同时“大幅”降低运营费用。

23andMe’s therapeutics division, which studied potential cancer treatments using its database of genetic material, will end all clinical trials, as the company considers licensing agreements or asset sales to “maximize” the program’s value.23andMe has had a turbulent past year, with the company confirming a data breach affecting 6.9 million users in 2023, revealing names, birth years, and ancestry information.

23andMe的治疗部门使用其遗传物质数据库研究了潜在的癌症治疗方法，该部门将结束所有临床试验，因为该公司考虑通过许可协议或资产销售来“最大化”该计划的价值。23andMe过去一年经历了动荡，该公司确认2023年有690万用户受到数据泄露的影响，泄露了姓名、出生年份和血统信息。

In September, 23andMe agreed to pay $30 million to affected customers following a class action lawsuit. Meanwhile, all of 23andMe’s board members resigned after rejecting CEO Anne Wojcicki’s plan to take the company private.“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” Wojcicki said in a statement.Comments.

9月，23andMe同意在集体诉讼后向受影响的客户支付3000万美元。与此同时，23andMe董事会全体成员在拒绝首席执行官安妮·沃西基（AnneWojcicki）将公司私有化的计划后辞职。Wojcicki在一份声明中表示：“我们正在采取这些困难但必要的行动，重组23andMe，专注于我们核心消费者业务和研究伙伴关系的长期成功。”。评论。